

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 8.29223310 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.90592482 |
| 3 | cytidine deamination (GO:0009972) | 6.77703902 |
| 4 | cytidine metabolic process (GO:0046087) | 6.77703902 |
| 5 | cytidine catabolic process (GO:0006216) | 6.77703902 |
| 6 | regulation of guanylate cyclase activity (GO:0031282) | 6.62780172 |
| 7 | NADH metabolic process (GO:0006734) | 6.15785972 |
| 8 | intestinal epithelial cell development (GO:0060576) | 6.01955876 |
| 9 | negative regulation of keratinocyte proliferation (GO:0010839) | 5.72847466 |
| 10 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.67725438 |
| 11 | sulfate transmembrane transport (GO:1902358) | 5.51446067 |
| 12 | epoxygenase P450 pathway (GO:0019373) | 5.50593767 |
| 13 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.41762924 |
| 14 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 5.23541565 |
| 15 | intestinal absorption (GO:0050892) | 5.19580455 |
| 16 | sulfate transport (GO:0008272) | 5.07116996 |
| 17 | lipoprotein transport (GO:0042953) | 4.97316727 |
| 18 | surfactant homeostasis (GO:0043129) | 4.88365555 |
| 19 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.85052614 |
| 20 | endocrine process (GO:0050886) | 4.76836857 |
| 21 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.76836857 |
| 22 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.76836857 |
| 23 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.76644143 |
| 24 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.76644143 |
| 25 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.75879062 |
| 26 | regulation of bile acid biosynthetic process (GO:0070857) | 4.73544753 |
| 27 | positive regulation of digestive system process (GO:0060456) | 4.70059966 |
| 28 | fructose metabolic process (GO:0006000) | 4.65883546 |
| 29 | intestinal cholesterol absorption (GO:0030299) | 4.65624711 |
| 30 | regulation of autophagic vacuole assembly (GO:2000785) | 4.63007357 |
| 31 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.62638023 |
| 32 | regulation of cellular extravasation (GO:0002691) | 4.60347219 |
| 33 | sulfur compound transport (GO:0072348) | 4.46643588 |
| 34 | cellular glucuronidation (GO:0052695) | 4.43853600 |
| 35 | daunorubicin metabolic process (GO:0044597) | 4.39854715 |
| 36 | polyketide metabolic process (GO:0030638) | 4.39854715 |
| 37 | doxorubicin metabolic process (GO:0044598) | 4.39854715 |
| 38 | digestion (GO:0007586) | 4.39207793 |
| 39 | regulation of vitamin metabolic process (GO:0030656) | 4.38892389 |
| 40 | uronic acid metabolic process (GO:0006063) | 4.36491290 |
| 41 | glucuronate metabolic process (GO:0019585) | 4.36491290 |
| 42 | transepithelial transport (GO:0070633) | 4.33683740 |
| 43 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.33571575 |
| 44 | drug transmembrane transport (GO:0006855) | 4.29583070 |
| 45 | regulation of systemic arterial blood pressure (GO:0003073) | 4.28148294 |
| 46 | sulfur amino acid catabolic process (GO:0000098) | 4.27835683 |
| 47 | renal system process involved in regulation of blood volume (GO:0001977) | 4.24690786 |
| 48 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.21169067 |
| 49 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.15389528 |
| 50 | urea cycle (GO:0000050) | 4.14961718 |
| 51 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.11557067 |
| 52 | negative regulation of epidermis development (GO:0045683) | 4.10806526 |
| 53 | regulation of vacuole organization (GO:0044088) | 4.09543101 |
| 54 | chemical homeostasis within a tissue (GO:0048875) | 4.07969355 |
| 55 | positive regulation of respiratory burst (GO:0060267) | 4.06326128 |
| 56 | regulation of cGMP biosynthetic process (GO:0030826) | 4.04624404 |
| 57 | positive regulation of pseudopodium assembly (GO:0031274) | 4.03470516 |
| 58 | diol metabolic process (GO:0034311) | 3.93482549 |
| 59 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.91297236 |
| 60 | urea metabolic process (GO:0019627) | 3.90862945 |
| 61 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.87814566 |
| 62 | flavonoid metabolic process (GO:0009812) | 3.86660270 |
| 63 | regulation of keratinocyte proliferation (GO:0010837) | 3.83572141 |
| 64 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.79773236 |
| 65 | cardiovascular system development (GO:0072358) | 3.78015786 |
| 66 | diacylglycerol metabolic process (GO:0046339) | 3.74836044 |
| 67 | keratinocyte development (GO:0003334) | 3.73884829 |
| 68 | hormone catabolic process (GO:0042447) | 3.71009503 |
| 69 | transcytosis (GO:0045056) | 3.69196611 |
| 70 | regulation of chemokine secretion (GO:0090196) | 3.69017750 |
| 71 | adhesion of symbiont to host cell (GO:0044650) | 3.63921770 |
| 72 | virion attachment to host cell (GO:0019062) | 3.63921770 |
| 73 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.63905252 |
| 74 | thyroid hormone metabolic process (GO:0042403) | 3.62741972 |
| 75 | drug transport (GO:0015893) | 3.62542626 |
| 76 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.62343044 |
| 77 | GDP-mannose metabolic process (GO:0019673) | 3.59448108 |
| 78 | regulation of pseudopodium assembly (GO:0031272) | 3.58437069 |
| 79 | nitrogen cycle metabolic process (GO:0071941) | 3.57566211 |
| 80 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.57512057 |
| 81 | renal absorption (GO:0070293) | 3.54715703 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 3.52560838 |
| 83 | ethanol oxidation (GO:0006069) | 3.52094577 |
| 84 | glycolipid catabolic process (GO:0019377) | 3.49861645 |
| 85 | glomerular filtration (GO:0003094) | 3.49683779 |
| 86 | bile acid and bile salt transport (GO:0015721) | 3.48401377 |
| 87 | peptide hormone processing (GO:0016486) | 3.44282486 |
| 88 | glycosphingolipid catabolic process (GO:0046479) | 3.42849415 |
| 89 | oligosaccharide biosynthetic process (GO:0009312) | 3.42553725 |
| 90 | peptide catabolic process (GO:0043171) | 3.40106196 |
| 91 | auditory receptor cell differentiation (GO:0042491) | 3.40050181 |
| 92 | membrane repolarization during action potential (GO:0086011) | 3.38594746 |
| 93 | O-glycan processing (GO:0016266) | 3.38269027 |
| 94 | thyroid hormone generation (GO:0006590) | 3.37767076 |
| 95 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.36553941 |
| 96 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.36168156 |
| 97 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.35841865 |
| 98 | drug catabolic process (GO:0042737) | 3.35562859 |
| 99 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.33623033 |
| 100 | sphingomyelin metabolic process (GO:0006684) | 3.32015689 |
| 101 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.31222977 |
| 102 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.27870875 |
| 103 | epithelial structure maintenance (GO:0010669) | 3.26525408 |
| 104 | regulation of cGMP metabolic process (GO:0030823) | 3.26460620 |
| 105 | homocysteine metabolic process (GO:0050667) | 3.24642085 |
| 106 | regulation of viral release from host cell (GO:1902186) | 3.23590762 |
| 107 | plasma lipoprotein particle assembly (GO:0034377) | 3.22846600 |
| 108 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.22225853 |
| 109 | sphingoid metabolic process (GO:0046519) | 3.21701913 |
| 110 | renal filtration (GO:0097205) | 3.21028388 |
| 111 | multicellular organismal water homeostasis (GO:0050891) | 3.20979725 |
| 112 | regulation of water loss via skin (GO:0033561) | 3.19983941 |
| 113 | excretion (GO:0007588) | 3.19056724 |
| 114 | ethanol metabolic process (GO:0006067) | 3.19030953 |
| 115 | regulation of triglyceride catabolic process (GO:0010896) | 3.18932868 |
| 116 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.16653740 |
| 117 | bicarbonate transport (GO:0015701) | 3.15286472 |
| 118 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.15276677 |
| 119 | antibacterial humoral response (GO:0019731) | 3.14144032 |
| 120 | organic cation transport (GO:0015695) | 3.13290360 |
| 121 | digestive system process (GO:0022600) | 3.12355454 |
| 122 | glandular epithelial cell differentiation (GO:0002067) | 3.11353720 |
| 123 | adhesion of symbiont to host (GO:0044406) | 3.11150438 |
| 124 | vitamin transport (GO:0051180) | 3.11115584 |
| 125 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.10792797 |
| 126 | antimicrobial humoral response (GO:0019730) | 3.06770160 |
| 127 | actin filament depolymerization (GO:0030042) | 3.06324087 |
| 128 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.04541393 |
| 129 | positive regulation of lipid catabolic process (GO:0050996) | 3.04153837 |
| 130 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.03880373 |
| 131 | regulation of respiratory burst (GO:0060263) | 3.02056390 |
| 132 | sodium ion homeostasis (GO:0055078) | 3.01614181 |
| 133 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.00665284 |
| 134 | regulation of epidermal cell differentiation (GO:0045604) | 2.99334906 |
| 135 | cellular modified amino acid catabolic process (GO:0042219) | 2.98300579 |
| 136 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.96375972 |
| 137 | cellular response to nitric oxide (GO:0071732) | 2.96170500 |
| 138 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.96111456 |
| 139 | establishment of skin barrier (GO:0061436) | 2.95049145 |
| 140 | protein-lipid complex assembly (GO:0065005) | 2.94985195 |
| 141 | exogenous drug catabolic process (GO:0042738) | 2.94610918 |
| 142 | positive regulation of epidermis development (GO:0045684) | 2.94360192 |
| 143 | arginine metabolic process (GO:0006525) | 2.93255608 |
| 144 | glycosylceramide metabolic process (GO:0006677) | 2.92704525 |
| 145 | vitamin transmembrane transport (GO:0035461) | 2.92557021 |
| 146 | protein retention in ER lumen (GO:0006621) | 2.90681828 |
| 147 | endocrine pancreas development (GO:0031018) | 2.90660423 |
| 148 | phosphate ion transport (GO:0006817) | 2.89096772 |
| 149 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.88542224 |
| 150 | primary alcohol catabolic process (GO:0034310) | 2.88318109 |
| 151 | cGMP-mediated signaling (GO:0019934) | 2.87998479 |
| 152 | lipoprotein metabolic process (GO:0042157) | 2.87277803 |
| 153 | desmosome organization (GO:0002934) | 2.87016674 |
| 154 | somite rostral/caudal axis specification (GO:0032525) | 2.86637537 |
| 155 | bile acid metabolic process (GO:0008206) | 2.86407421 |
| 156 | alkaloid metabolic process (GO:0009820) | 2.85098014 |
| 157 | receptor recycling (GO:0001881) | 2.84928540 |
| 158 | fucose metabolic process (GO:0006004) | 2.84684343 |
| 159 | cGMP biosynthetic process (GO:0006182) | 2.84014144 |
| 160 | arachidonic acid secretion (GO:0050482) | 2.83813590 |
| 161 | icosanoid secretion (GO:0032309) | 2.83813590 |
| 162 | icosanoid transport (GO:0071715) | 2.82640511 |
| 163 | fatty acid derivative transport (GO:1901571) | 2.82640511 |
| 164 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.81671132 |
| 165 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.81591070 |
| 166 | phosphate ion transmembrane transport (GO:0035435) | 2.79647136 |
| 167 | vitamin A metabolic process (GO:0006776) | 2.79485712 |
| 168 | modified amino acid transport (GO:0072337) | 2.79191764 |
| 169 | drug metabolic process (GO:0017144) | 2.78674203 |
| 170 | glycoside metabolic process (GO:0016137) | 2.77639090 |
| 171 | cellular response to vitamin D (GO:0071305) | 2.76515685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.35508697 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.94442496 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.80062046 |
| 4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.41317117 |
| 5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.41317117 |
| 6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.41317117 |
| 7 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.13885172 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.08972463 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.00326288 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.88793053 |
| 11 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.81534636 |
| 12 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.77273673 |
| 13 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.71400699 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.64249250 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.43302639 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.18564982 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.08990593 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.07045003 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 1.99482382 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97469836 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.95871357 |
| 22 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.93162268 |
| 23 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.90982705 |
| 24 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.89884686 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.83887103 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.83655405 |
| 27 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.83566045 |
| 28 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.80458330 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.79321441 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.76197171 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75335336 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.71171932 |
| 33 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.69588293 |
| 34 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65453560 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64652835 |
| 36 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.64543487 |
| 37 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.62668732 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.60812590 |
| 39 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57247896 |
| 40 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.55358232 |
| 41 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.52908367 |
| 42 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.49614066 |
| 43 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.45818000 |
| 44 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.43521950 |
| 45 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.43108565 |
| 46 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39849300 |
| 47 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38021272 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37195244 |
| 49 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.36989899 |
| 50 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.36013640 |
| 51 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.34484997 |
| 52 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.33750257 |
| 53 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.33301147 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31967574 |
| 55 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29936899 |
| 56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.29640746 |
| 57 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.28188879 |
| 58 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.26876560 |
| 59 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.26636952 |
| 60 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.25386929 |
| 61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24011061 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23017096 |
| 63 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.19182975 |
| 64 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18876711 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18874662 |
| 66 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17821763 |
| 67 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17410825 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15743178 |
| 69 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.15035510 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14949983 |
| 71 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.14351788 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.12675498 |
| 73 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10912752 |
| 74 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10831404 |
| 75 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09810682 |
| 76 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09092936 |
| 77 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.08809019 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07246934 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06106890 |
| 80 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.04711431 |
| 81 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04155894 |
| 82 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04024763 |
| 83 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03628994 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03463954 |
| 85 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02539525 |
| 86 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02183469 |
| 87 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01203519 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00492652 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99728460 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99698865 |
| 91 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98991135 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.98918822 |
| 93 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98481891 |
| 94 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.97019251 |
| 95 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96756792 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95385052 |
| 97 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.94642707 |
| 98 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.94146098 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93545140 |
| 100 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.93459800 |
| 101 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.92485691 |
| 102 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.92399632 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91579426 |
| 104 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.90914473 |
| 105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90361299 |
| 106 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90148912 |
| 107 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89671242 |
| 108 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89448082 |
| 109 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89190147 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87593633 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.87559360 |
| 112 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.87357738 |
| 113 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.87283732 |
| 114 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87220796 |
| 115 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87140617 |
| 116 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87074387 |
| 117 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.86477308 |
| 118 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86389362 |
| 119 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85977911 |
| 120 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85561784 |
| 121 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85018037 |
| 122 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85018037 |
| 123 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.85010834 |
| 124 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84903952 |
| 125 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84705434 |
| 126 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.84255852 |
| 127 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83893920 |
| 128 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83723124 |
| 129 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.83439031 |
| 130 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82945990 |
| 131 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.82429710 |
| 132 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81671690 |
| 133 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81284419 |
| 134 | ATF3_27146783_Chip-Seq_COLON_Human | 0.80637118 |
| 135 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.80614330 |
| 136 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79731565 |
| 137 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79255346 |
| 138 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78824128 |
| 139 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77965736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 5.62255467 |
| 2 | MP0003283_abnormal_digestive_organ | 4.18834218 |
| 3 | MP0001666_abnormal_nutrient_absorption | 4.11499791 |
| 4 | MP0004043_abnormal_pH_regulation | 3.98360402 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.96943548 |
| 6 | MP0008004_abnormal_stomach_pH | 3.79874475 |
| 7 | MP0005360_urolithiasis | 3.31266163 |
| 8 | MP0000462_abnormal_digestive_system | 2.93761871 |
| 9 | MP0009840_abnormal_foam_cell | 2.89713452 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.81516586 |
| 11 | MP0004147_increased_porphyrin_level | 2.75383698 |
| 12 | MP0004782_abnormal_surfactant_physiolog | 2.59867712 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.53551253 |
| 14 | MP0002277_abnormal_respiratory_mucosa | 2.44079280 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.40135927 |
| 16 | MP0003315_abnormal_perineum_morphology | 2.29798219 |
| 17 | MP0001664_abnormal_digestion | 2.22492475 |
| 18 | MP0009643_abnormal_urine_homeostasis | 2.19088638 |
| 19 | MP0001765_abnormal_ion_homeostasis | 2.17750869 |
| 20 | MP0005083_abnormal_biliary_tract | 2.13810196 |
| 21 | MP0008875_abnormal_xenobiotic_pharmacok | 2.11894078 |
| 22 | MP0005409_darkened_coat_color | 2.08858978 |
| 23 | MP0000678_abnormal_parathyroid_gland | 2.08705407 |
| 24 | MP0000490_abnormal_crypts_of | 2.04295421 |
| 25 | MP0001873_stomach_inflammation | 2.03669322 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 2.03149231 |
| 27 | MP0005365_abnormal_bile_salt | 2.03061408 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.98075985 |
| 29 | MP0003252_abnormal_bile_duct | 1.92938237 |
| 30 | MP0002098_abnormal_vibrissa_morphology | 1.84905367 |
| 31 | MP0003878_abnormal_ear_physiology | 1.83757224 |
| 32 | MP0005377_hearing/vestibular/ear_phenot | 1.83757224 |
| 33 | MP0003866_abnormal_defecation | 1.83698597 |
| 34 | MP0005381_digestive/alimentary_phenotyp | 1.82909308 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.76425646 |
| 36 | MP0002132_abnormal_respiratory_system | 1.75524785 |
| 37 | MP0001663_abnormal_digestive_system | 1.72581558 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.69720299 |
| 39 | MP0010329_abnormal_lipoprotein_level | 1.66750971 |
| 40 | MP0009379_abnormal_foot_pigmentation | 1.63017605 |
| 41 | MP0001756_abnormal_urination | 1.62698343 |
| 42 | MP0005220_abnormal_exocrine_pancreas | 1.59060420 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.55700478 |
| 44 | MP0003868_abnormal_feces_composition | 1.48777456 |
| 45 | MP0000613_abnormal_salivary_gland | 1.46902180 |
| 46 | MP0000477_abnormal_intestine_morphology | 1.44687318 |
| 47 | MP0010678_abnormal_skin_adnexa | 1.44478570 |
| 48 | MP0005166_decreased_susceptibility_to | 1.39980272 |
| 49 | MP0000537_abnormal_urethra_morphology | 1.35701846 |
| 50 | MP0005332_abnormal_amino_acid | 1.33498290 |
| 51 | MP0000762_abnormal_tongue_morphology | 1.27777122 |
| 52 | MP0002136_abnormal_kidney_physiology | 1.26530224 |
| 53 | MP0005310_abnormal_salivary_gland | 1.25972262 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.23801580 |
| 55 | MP0002796_impaired_skin_barrier | 1.23537993 |
| 56 | MP0000470_abnormal_stomach_morphology | 1.23439933 |
| 57 | MP0001849_ear_inflammation | 1.22095720 |
| 58 | MP0003879_abnormal_hair_cell | 1.18769223 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.18111327 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.17981129 |
| 61 | MP0000538_abnormal_urinary_bladder | 1.16126336 |
| 62 | MP0005257_abnormal_intraocular_pressure | 1.15277477 |
| 63 | MP0003011_delayed_dark_adaptation | 1.15044680 |
| 64 | MP0002234_abnormal_pharynx_morphology | 1.14310325 |
| 65 | MP0005670_abnormal_white_adipose | 1.11865339 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 1.09919666 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.08561280 |
| 68 | MP0001764_abnormal_homeostasis | 1.07485408 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 1.01535442 |
| 70 | MP0001188_hyperpigmentation | 1.01415728 |
| 71 | MP0002254_reproductive_system_inflammat | 0.99776750 |
| 72 | MP0000566_synostosis | 0.96014113 |
| 73 | MP0000609_abnormal_liver_physiology | 0.93227174 |
| 74 | MP0001485_abnormal_pinna_reflex | 0.92989808 |
| 75 | MP0002928_abnormal_bile_duct | 0.89782703 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 0.88603728 |
| 77 | MP0008961_abnormal_basal_metabolism | 0.86747273 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 0.85808655 |
| 79 | MP0005448_abnormal_energy_balance | 0.82162076 |
| 80 | MP0003045_fibrosis | 0.81543155 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.80462446 |
| 82 | MP0001958_emphysema | 0.80417123 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 0.79096244 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.77585250 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77489825 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.77172281 |
| 87 | MP0002971_abnormal_brown_adipose | 0.76263815 |
| 88 | MP0001944_abnormal_pancreas_morphology | 0.74826362 |
| 89 | MP0002009_preneoplasia | 0.74548646 |
| 90 | MP0005666_abnormal_adipose_tissue | 0.74317717 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.73521522 |
| 92 | MP0004270_analgesia | 0.73208510 |
| 93 | MP0001881_abnormal_mammary_gland | 0.71596008 |
| 94 | MP0000681_abnormal_thyroid_gland | 0.71285076 |
| 95 | MP0009780_abnormal_chondrocyte_physiolo | 0.70800234 |
| 96 | MP0005499_abnormal_olfactory_system | 0.70417483 |
| 97 | MP0005394_taste/olfaction_phenotype | 0.70417483 |
| 98 | MP0004947_skin_inflammation | 0.68828011 |
| 99 | MP0000377_abnormal_hair_follicle | 0.68519570 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.68250245 |
| 101 | MP0003806_abnormal_nucleotide_metabolis | 0.67779826 |
| 102 | MP0000383_abnormal_hair_follicle | 0.66511166 |
| 103 | MP0002006_tumorigenesis | 0.66188641 |
| 104 | MP0008872_abnormal_physiological_respon | 0.66090605 |
| 105 | MP0003718_maternal_effect | 0.66025321 |
| 106 | MP0003724_increased_susceptibility_to | 0.65838024 |
| 107 | MP0009115_abnormal_fat_cell | 0.65554141 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.65515446 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.65408825 |
| 110 | MP0004272_abnormal_basement_membrane | 0.64159900 |
| 111 | MP0009053_abnormal_anal_canal | 0.63268514 |
| 112 | MP0009642_abnormal_blood_homeostasis | 0.62549794 |
| 113 | MP0002233_abnormal_nose_morphology | 0.62160265 |
| 114 | MP0002822_catalepsy | 0.62076660 |
| 115 | MP0009785_altered_susceptibility_to | 0.61505136 |
| 116 | MP0005501_abnormal_skin_physiology | 0.61234882 |
| 117 | MP0001501_abnormal_sleep_pattern | 0.60555868 |
| 118 | MP0002896_abnormal_bone_mineralization | 0.59984248 |
| 119 | MP0003186_abnormal_redox_activity | 0.59297979 |
| 120 | MP0003890_abnormal_embryonic-extraembry | 0.58966966 |
| 121 | MP0000163_abnormal_cartilage_morphology | 0.58489097 |
| 122 | MP0000627_abnormal_mammary_gland | 0.58387280 |
| 123 | MP0000467_abnormal_esophagus_morphology | 0.58175857 |
| 124 | MP0005535_abnormal_body_temperature | 0.58152877 |
| 125 | MP0005451_abnormal_body_composition | 0.55696440 |
| 126 | MP0003938_abnormal_ear_development | 0.55509569 |
| 127 | MP0002118_abnormal_lipid_homeostasis | 0.55387349 |
| 128 | MP0003953_abnormal_hormone_level | 0.54692080 |
| 129 | MP0005165_increased_susceptibility_to | 0.54689611 |
| 130 | MP0003329_amyloid_beta_deposits | 0.54674333 |
| 131 | MP0008469_abnormal_protein_level | 0.54220502 |
| 132 | MP0005408_hypopigmentation | 0.53436290 |
| 133 | MP0002932_abnormal_joint_morphology | 0.52875731 |
| 134 | MP0004858_abnormal_nervous_system | 0.51337207 |
| 135 | MP0003941_abnormal_skin_development | 0.50781105 |
| 136 | MP0000049_abnormal_middle_ear | 0.48162750 |
| 137 | MP0003566_abnormal_cell_adhesion | 0.44663137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 6.98103233 |
| 2 | Abnormality of chloride homeostasis (HP:0011422) | 5.67104208 |
| 3 | Abnormality of proline metabolism (HP:0010907) | 5.66465390 |
| 4 | Hydroxyprolinuria (HP:0003080) | 5.66465390 |
| 5 | Metabolic alkalosis (HP:0200114) | 4.96777504 |
| 6 | Gout (HP:0001997) | 4.42516993 |
| 7 | Chronic diarrhea (HP:0002028) | 4.37784583 |
| 8 | Fat malabsorption (HP:0002630) | 4.26159249 |
| 9 | Hyperaldosteronism (HP:0000859) | 4.13753053 |
| 10 | Abnormality of renin-angiotensin system (HP:0000847) | 4.03788017 |
| 11 | Flat acetabular roof (HP:0003180) | 4.02794834 |
| 12 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.02553868 |
| 13 | Renal salt wasting (HP:0000127) | 4.02284709 |
| 14 | Congenital sensorineural hearing impairment (HP:0008527) | 4.01937606 |
| 15 | Ileus (HP:0002595) | 4.00509712 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 3.77609635 |
| 17 | Abnormality of vitamin B metabolism (HP:0004340) | 3.74064965 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.73188937 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 3.52179792 |
| 20 | Hypokalemic alkalosis (HP:0001949) | 3.51468636 |
| 21 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.48340282 |
| 22 | Abdominal distention (HP:0003270) | 3.41649482 |
| 23 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.40553628 |
| 24 | Posterior subcapsular cataract (HP:0007787) | 3.26658196 |
| 25 | Abnormality of vitamin metabolism (HP:0100508) | 3.24124592 |
| 26 | Right ventricular cardiomyopathy (HP:0011663) | 3.12390574 |
| 27 | Acanthocytosis (HP:0001927) | 3.12100500 |
| 28 | Ventricular fibrillation (HP:0001663) | 3.10998510 |
| 29 | Malnutrition (HP:0004395) | 3.10974656 |
| 30 | Confusion (HP:0001289) | 3.10355763 |
| 31 | Hyperparathyroidism (HP:0000843) | 3.09560743 |
| 32 | Neonatal short-limb short stature (HP:0008921) | 3.08248223 |
| 33 | Alkalosis (HP:0001948) | 3.08006722 |
| 34 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.03250485 |
| 35 | Villous atrophy (HP:0011473) | 3.03250485 |
| 36 | Abnormal hemoglobin (HP:0011902) | 2.99866793 |
| 37 | Dehydration (HP:0001944) | 2.99111029 |
| 38 | Flat capital femoral epiphysis (HP:0003370) | 2.97241480 |
| 39 | Pigmentary retinal degeneration (HP:0001146) | 2.95279970 |
| 40 | Abnormal cartilage morphology (HP:0002763) | 2.94228429 |
| 41 | Increased purine levels (HP:0004368) | 2.92537014 |
| 42 | Hyperuricemia (HP:0002149) | 2.92537014 |
| 43 | Glycosuria (HP:0003076) | 2.86933485 |
| 44 | Abnormality of urine glucose concentration (HP:0011016) | 2.86933485 |
| 45 | Decreased circulating renin level (HP:0003351) | 2.84878246 |
| 46 | Hypomagnesemia (HP:0002917) | 2.81991049 |
| 47 | Abnormality of renal excretion (HP:0011036) | 2.80243647 |
| 48 | Wide cranial sutures (HP:0010537) | 2.78618886 |
| 49 | Hemorrhage of the eye (HP:0011885) | 2.78574646 |
| 50 | Abnormality of carpal bone ossification (HP:0006257) | 2.77671759 |
| 51 | Hyperammonemia (HP:0001987) | 2.76585347 |
| 52 | Abnormality of magnesium homeostasis (HP:0004921) | 2.72741532 |
| 53 | Increased circulating renin level (HP:0000848) | 2.72396958 |
| 54 | Abnormal tarsal ossification (HP:0008369) | 2.71713231 |
| 55 | Shawl scrotum (HP:0000049) | 2.69363926 |
| 56 | Steatorrhea (HP:0002570) | 2.68339591 |
| 57 | Hyponatremia (HP:0002902) | 2.68126875 |
| 58 | Hypokalemia (HP:0002900) | 2.67223657 |
| 59 | Cheilitis (HP:0100825) | 2.64138034 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.58233710 |
| 61 | Nausea (HP:0002018) | 2.56988356 |
| 62 | Hyperglycinuria (HP:0003108) | 2.56320745 |
| 63 | Hyperphosphatemia (HP:0002905) | 2.53777037 |
| 64 | Abnormality of the 1st metacarpal (HP:0010009) | 2.52729652 |
| 65 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51819115 |
| 66 | Nephrolithiasis (HP:0000787) | 2.51081355 |
| 67 | Hyperphosphaturia (HP:0003109) | 2.50613539 |
| 68 | Tetany (HP:0001281) | 2.48850098 |
| 69 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.47331937 |
| 70 | Abnormality of glycine metabolism (HP:0010895) | 2.47331937 |
| 71 | Widely patent fontanelles and sutures (HP:0004492) | 2.46634594 |
| 72 | Abnormality of potassium homeostasis (HP:0011042) | 2.43765996 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.43321315 |
| 74 | Cupped ribs (HP:0000887) | 2.43156955 |
| 75 | Short middle phalanx of finger (HP:0005819) | 2.42988255 |
| 76 | Xanthomatosis (HP:0000991) | 2.41828409 |
| 77 | Proximal tubulopathy (HP:0000114) | 2.41513431 |
| 78 | Micronodular cirrhosis (HP:0001413) | 2.40958544 |
| 79 | Intrahepatic cholestasis (HP:0001406) | 2.40349324 |
| 80 | Visceral angiomatosis (HP:0100761) | 2.40328584 |
| 81 | Flattened epiphyses (HP:0003071) | 2.38772378 |
| 82 | Abnormal urine phosphate concentration (HP:0012599) | 2.37714063 |
| 83 | Renal tubular acidosis (HP:0001947) | 2.36791610 |
| 84 | Tubulointerstitial fibrosis (HP:0005576) | 2.35186550 |
| 85 | Partial duplication of thumb phalanx (HP:0009944) | 2.33595416 |
| 86 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.32794761 |
| 87 | Pustule (HP:0200039) | 2.32299610 |
| 88 | Focal segmental glomerulosclerosis (HP:0000097) | 2.32197256 |
| 89 | Pili torti (HP:0003777) | 2.31953498 |
| 90 | Growth hormone excess (HP:0000845) | 2.27044782 |
| 91 | Subcapsular cataract (HP:0000523) | 2.26177834 |
| 92 | Eczematoid dermatitis (HP:0000976) | 2.25792113 |
| 93 | Abnormal urine output (HP:0012590) | 2.24756156 |
| 94 | Glomerulonephritis (HP:0000099) | 2.23306748 |
| 95 | Chronic bronchitis (HP:0004469) | 2.22958097 |
| 96 | Abnormality of sodium homeostasis (HP:0010931) | 2.22905481 |
| 97 | Spinal cord compression (HP:0002176) | 2.22294697 |
| 98 | Abnormal hair laboratory examination (HP:0003328) | 2.20968232 |
| 99 | Conjugated hyperbilirubinemia (HP:0002908) | 2.20314708 |
| 100 | Megaloblastic anemia (HP:0001889) | 2.20251626 |
| 101 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.19736911 |
| 102 | Bilateral microphthalmos (HP:0007633) | 2.18395721 |
| 103 | Hyperkalemia (HP:0002153) | 2.17843425 |
| 104 | Interstitial pulmonary disease (HP:0006530) | 2.16063105 |
| 105 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.13994862 |
| 106 | Fragile nails (HP:0001808) | 2.13960428 |
| 107 | Hemangiomatosis (HP:0007461) | 2.13700460 |
| 108 | Polyuria (HP:0000103) | 2.13490935 |
| 109 | Enlarged epiphyses (HP:0010580) | 2.11589489 |
| 110 | Hypotension (HP:0002615) | 2.07333562 |
| 111 | Metabolic acidosis (HP:0001942) | 2.06227153 |
| 112 | Large earlobe (HP:0009748) | 2.04192978 |
| 113 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.03321510 |
| 114 | Protuberant abdomen (HP:0001538) | 2.03062144 |
| 115 | Abnormal hand bone ossification (HP:0010660) | 2.02133093 |
| 116 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.01529944 |
| 117 | Dicarboxylic aciduria (HP:0003215) | 2.01529944 |
| 118 | Delayed epiphyseal ossification (HP:0002663) | 2.00607081 |
| 119 | Tracheal stenosis (HP:0002777) | 2.00152467 |
| 120 | Tachypnea (HP:0002789) | 1.99938121 |
| 121 | Curly hair (HP:0002212) | 1.99867909 |
| 122 | Premature loss of primary teeth (HP:0006323) | 1.99320106 |
| 123 | Adrenal overactivity (HP:0002717) | 1.97757328 |
| 124 | Potter facies (HP:0002009) | 1.97714706 |
| 125 | Facial shape deformation (HP:0011334) | 1.97714706 |
| 126 | Abnormality of nucleobase metabolism (HP:0010932) | 1.97540713 |
| 127 | Hypophosphatemia (HP:0002148) | 1.96678877 |
| 128 | Glomerulosclerosis (HP:0000096) | 1.95824467 |
| 129 | Cerebral palsy (HP:0100021) | 1.94888305 |
| 130 | Nephritis (HP:0000123) | 1.92850635 |
| 131 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.92229651 |
| 132 | Hypoplasia of the uterus (HP:0000013) | 1.91700801 |
| 133 | Abnormality of renal resorption (HP:0011038) | 1.90623836 |
| 134 | Abnormal biliary tract morphology (HP:0012440) | 1.90553205 |
| 135 | Thin bony cortex (HP:0002753) | 1.89823149 |
| 136 | Abnormal glucose tolerance (HP:0001952) | 1.89260260 |
| 137 | Abnormal pancreas size (HP:0012094) | 1.88974130 |
| 138 | Hypolipoproteinemia (HP:0010981) | 1.88831258 |
| 139 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.88609609 |
| 140 | Reduced antithrombin III activity (HP:0001976) | 1.88413772 |
| 141 | Symptomatic seizures (HP:0011145) | 1.87684808 |
| 142 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.87226973 |
| 143 | Abnormality of the costochondral junction (HP:0000919) | 1.86666610 |
| 144 | Biliary tract neoplasm (HP:0100574) | 1.85848603 |
| 145 | Bone pain (HP:0002653) | 1.85683655 |
| 146 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.85672222 |
| 147 | Pancreatitis (HP:0001733) | 1.85222993 |
| 148 | Abnormal ossification of hand bones (HP:0005921) | 1.84840329 |
| 149 | Abnormality of complement system (HP:0005339) | 1.84321875 |
| 150 | Multiple lipomas (HP:0001012) | 1.84050399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 7.90686884 |
| 2 | ACVR1B | 5.53379780 |
| 3 | FRK | 3.61552130 |
| 4 | EPHB2 | 3.29346542 |
| 5 | MST1R | 3.21673459 |
| 6 | LMTK2 | 3.21595425 |
| 7 | WNK4 | 2.91839478 |
| 8 | MST4 | 2.75563691 |
| 9 | GRK6 | 2.62331982 |
| 10 | MAP2K2 | 2.59015727 |
| 11 | GRK1 | 2.49272952 |
| 12 | ERN1 | 2.47246996 |
| 13 | TRIB3 | 2.40206063 |
| 14 | CDK12 | 2.34211869 |
| 15 | OXSR1 | 2.17873419 |
| 16 | PRKG2 | 2.17871920 |
| 17 | MAP3K10 | 2.13833044 |
| 18 | PIK3CA | 2.10578983 |
| 19 | STK39 | 2.06398391 |
| 20 | EPHA2 | 1.92434565 |
| 21 | FGFR4 | 1.92383732 |
| 22 | RIPK1 | 1.91597603 |
| 23 | MAP3K12 | 1.87207405 |
| 24 | PBK | 1.73220342 |
| 25 | GRK5 | 1.72308555 |
| 26 | TESK2 | 1.62328260 |
| 27 | MAP3K2 | 1.61288321 |
| 28 | NME1 | 1.53266217 |
| 29 | TTK | 1.50671894 |
| 30 | TGFBR2 | 1.49190087 |
| 31 | EPHA3 | 1.40532084 |
| 32 | WNK3 | 1.37210611 |
| 33 | STK24 | 1.36885998 |
| 34 | BLK | 1.32055775 |
| 35 | BCKDK | 1.29524768 |
| 36 | WNK1 | 1.25969948 |
| 37 | MAP2K6 | 1.21751313 |
| 38 | MAPK15 | 1.21086906 |
| 39 | STK38L | 1.20155958 |
| 40 | MATK | 1.19293605 |
| 41 | PKN2 | 1.19116910 |
| 42 | NUAK1 | 1.15737973 |
| 43 | MET | 1.15519658 |
| 44 | SIK1 | 1.10899406 |
| 45 | PTK2 | 1.10611086 |
| 46 | MYLK | 1.09744599 |
| 47 | ADRBK2 | 1.09156324 |
| 48 | SMG1 | 1.08987321 |
| 49 | MAPKAPK3 | 1.05630353 |
| 50 | PRKCI | 1.00803109 |
| 51 | STK10 | 1.00197372 |
| 52 | TYK2 | 0.96721876 |
| 53 | ERBB2 | 0.94861246 |
| 54 | FGFR3 | 0.94776495 |
| 55 | PAK4 | 0.94015406 |
| 56 | INSRR | 0.91028116 |
| 57 | AKT3 | 0.89081066 |
| 58 | GRK7 | 0.85927972 |
| 59 | IRAK3 | 0.84119814 |
| 60 | NEK6 | 0.80214152 |
| 61 | PTK6 | 0.78526970 |
| 62 | EEF2K | 0.71170286 |
| 63 | PRPF4B | 0.71111752 |
| 64 | MAP3K14 | 0.69881362 |
| 65 | MAP3K3 | 0.68083900 |
| 66 | FER | 0.67543588 |
| 67 | SCYL2 | 0.66079622 |
| 68 | PIK3CG | 0.63460227 |
| 69 | RET | 0.61643686 |
| 70 | PDK1 | 0.58070224 |
| 71 | LRRK2 | 0.57980969 |
| 72 | TAOK1 | 0.57468937 |
| 73 | CSK | 0.56239458 |
| 74 | PDK2 | 0.55833292 |
| 75 | MAP2K1 | 0.55765985 |
| 76 | MAPK11 | 0.55752233 |
| 77 | RPS6KB2 | 0.54145471 |
| 78 | DDR2 | 0.52859637 |
| 79 | DYRK1B | 0.52423293 |
| 80 | EPHB1 | 0.52341799 |
| 81 | AURKB | 0.51784813 |
| 82 | LATS1 | 0.51060119 |
| 83 | TLK1 | 0.48792074 |
| 84 | RIPK4 | 0.47247160 |
| 85 | YES1 | 0.46939947 |
| 86 | KSR2 | 0.46846195 |
| 87 | HIPK2 | 0.46678008 |
| 88 | BMPR2 | 0.46230491 |
| 89 | MAP3K7 | 0.44860703 |
| 90 | NLK | 0.43638667 |
| 91 | RPS6KA2 | 0.43315495 |
| 92 | MOS | 0.42088187 |
| 93 | PRKAA2 | 0.41621581 |
| 94 | MAP4K1 | 0.41452665 |
| 95 | ADRBK1 | 0.41450089 |
| 96 | PRKCZ | 0.41417301 |
| 97 | MAP3K1 | 0.41233533 |
| 98 | NTRK1 | 0.40052283 |
| 99 | PRKD2 | 0.39201557 |
| 100 | IRAK1 | 0.38194764 |
| 101 | ICK | 0.38173468 |
| 102 | PRKACG | 0.37327075 |
| 103 | CAMK2G | 0.34907903 |
| 104 | CDC42BPA | 0.32540099 |
| 105 | MAPK7 | 0.32516100 |
| 106 | DMPK | 0.32504029 |
| 107 | PDGFRA | 0.32314960 |
| 108 | ABL2 | 0.31370608 |
| 109 | MAPKAPK2 | 0.31031963 |
| 110 | ILK | 0.30842784 |
| 111 | BCR | 0.29593092 |
| 112 | CSF1R | 0.28797347 |
| 113 | JAK1 | 0.27947156 |
| 114 | PRKCD | 0.27712184 |
| 115 | EIF2AK2 | 0.27212215 |
| 116 | CDK6 | 0.26248057 |
| 117 | MARK2 | 0.25531664 |
| 118 | CDK7 | 0.24559359 |
| 119 | GSK3A | 0.24109130 |
| 120 | PRKCQ | 0.23527189 |
| 121 | DAPK2 | 0.23225234 |
| 122 | MUSK | 0.22902370 |
| 123 | CAMK2D | 0.22817656 |
| 124 | PRKCA | 0.22245840 |
| 125 | AKT2 | 0.22140148 |
| 126 | JAK2 | 0.20550121 |
| 127 | FYN | 0.20407168 |
| 128 | BMX | 0.20387517 |
| 129 | EPHA4 | 0.19732545 |
| 130 | IKBKE | 0.19159312 |
| 131 | MAP3K11 | 0.18963683 |
| 132 | PDGFRB | 0.18918078 |
| 133 | TIE1 | 0.18796151 |
| 134 | CHUK | 0.17936986 |
| 135 | PDPK1 | 0.17757692 |
| 136 | PRKAA1 | 0.17105443 |
| 137 | SRC | 0.16819040 |
| 138 | PAK3 | 0.16415871 |
| 139 | CAMK4 | 0.15867268 |
| 140 | IGF1R | 0.15645429 |
| 141 | TESK1 | 0.14996684 |
| 142 | TBK1 | 0.14868504 |
| 143 | ZAP70 | 0.13531937 |
| 144 | MELK | 0.13441471 |
| 145 | PASK | 0.12823681 |
| 146 | PLK1 | 0.12756437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.96675768 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.82840686 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 3.44786394 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.70941121 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.65011374 |
| 6 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.55866718 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.32569602 |
| 8 | Pancreatic secretion_Homo sapiens_hsa04972 | 2.30808292 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.28246071 |
| 10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.22400676 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.16383493 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.11307480 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.99181051 |
| 14 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.88240098 |
| 15 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.86495439 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.86380583 |
| 17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.83293615 |
| 18 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.79540403 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77637949 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.76216828 |
| 21 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.73265164 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.71975091 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.71597158 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.68354943 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.64161531 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.62463053 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62308256 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.59901884 |
| 29 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.51082041 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.49412775 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.48450895 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.44492392 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.41104809 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32368903 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.27187512 |
| 36 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.25927030 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25874650 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.23588677 |
| 39 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.22268735 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19088855 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17977929 |
| 42 | Tight junction_Homo sapiens_hsa04530 | 1.15214652 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.14599972 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.09791794 |
| 45 | Protein export_Homo sapiens_hsa03060 | 1.03792095 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03419561 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.02053055 |
| 48 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.93660516 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93499152 |
| 50 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92683836 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90885019 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.90254205 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89754497 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89301956 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83014485 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.79829519 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77525244 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76223925 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.75737868 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73577852 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73068142 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69350293 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69298325 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.68977491 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66762632 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 0.63601381 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62950375 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62562306 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61609538 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60394322 |
| 71 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60153499 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58799552 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58631894 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57073170 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.56598476 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.56034364 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54613896 |
| 78 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52134947 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51260720 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51094633 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50641921 |
| 82 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.47570154 |
| 83 | Allograft rejection_Homo sapiens_hsa05330 | 0.47242337 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.47184226 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45917175 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.45001769 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44315846 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.44309977 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43745941 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.43034401 |
| 91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.40088944 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38739323 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38625806 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.38520801 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38360104 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37988761 |
| 97 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.37695684 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37481175 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37097933 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35395925 |
| 101 | Renin secretion_Homo sapiens_hsa04924 | 0.35092084 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.34097210 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31863369 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.31861156 |
| 105 | Salivary secretion_Homo sapiens_hsa04970 | 0.29897860 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28737897 |
| 107 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28684400 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.27695331 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.26174425 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.25408349 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.23983550 |
| 112 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.20568525 |
| 113 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.19011525 |
| 114 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.18923299 |
| 115 | Ribosome_Homo sapiens_hsa03010 | 0.18825922 |
| 116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.18715856 |
| 117 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.17786062 |
| 118 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.17549061 |
| 119 | Taste transduction_Homo sapiens_hsa04742 | 0.16447075 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.15336603 |
| 121 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.14706680 |
| 122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.14478599 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14133161 |
| 124 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.12930015 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11022759 |
| 126 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.09299070 |
| 127 | Leishmaniasis_Homo sapiens_hsa05140 | 0.08279698 |
| 128 | Cocaine addiction_Homo sapiens_hsa05030 | 0.06502790 |
| 129 | Insulin secretion_Homo sapiens_hsa04911 | 0.06245630 |
| 130 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.05478193 |
| 131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.03070943 |

